SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001209
Filing Date
2018-03-01
Accepted
2018-03-01 16:32:12
Documents
88
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234682z10-k.htm 10-K 1630689
2 EX-10.9(A) a2234682zex-10_9a.htm EX-10.9(A) 79105
3 EX-10.9(B) a2234682zex-10_9b.htm EX-10.9(B) 77716
4 EX-21.1 a2234682zex-21_1.htm EX-21.1 5438
5 EX-23.1 a2234682zex-23_1.htm EX-23.1 2703
6 EX-31.1 a2234682zex-31_1.htm EX-31.1 7985
7 EX-31.2 a2234682zex-31_2.htm EX-31.2 7954
8 EX-32.1 a2234682zex-32_1.htm EX-32.1 5805
15 G863102.JPG g863102.jpg GRAPHIC 118655
16 G843870.JPG g843870.jpg GRAPHIC 74658
17 G526457.JPG g526457.jpg GRAPHIC 69565
18 G499308.JPG g499308.jpg GRAPHIC 60239
  Complete submission text file 0001047469-18-001209.txt   8925881

Data Files

Seq Description Document Type Size
9 EX-101.INS crvs-20171231.xml EX-101.INS 2217459
10 EX-101.SCH crvs-20171231.xsd EX-101.SCH 56999
11 EX-101.CAL crvs-20171231_cal.xml EX-101.CAL 62007
12 EX-101.DEF crvs-20171231_def.xml EX-101.DEF 172940
13 EX-101.LAB crvs-20171231_lab.xml EX-101.LAB 530598
14 EX-101.PRE crvs-20171231_pre.xml EX-101.PRE 376820
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 18657886
SIC: 2834 Pharmaceutical Preparations